Has Rohinton Morris, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,302 in general payments to Rohinton Morris, MD across 254 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rohinton Morris, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rohinton Morris, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rohinton Morris, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · West Reading, PANPI 1346271038

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,315 of the $20,302 with a category attached, or 70.5%. Abbott accounts for 64.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $5,858 and has fallen 90.1% since, to $578 in 2025.

$20,302in general payments, 2019–2025

Across 254 payments — averaging $79.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$13K
Atricure, Inc.$3K
Edwards Lifesciences$2K
Medtronic$458
Artivion, Inc.$342
Baxter Healthcare$335
plus $1K from 18 others

What the payments were for

Consulting fees$5,75028%
Travel & lodging$2371%
Food & beverage$14,31571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	127	$13,116
Atricure, Inc.	49	$3,278
Edwards Lifesciences	24	$1,602
Medtronic(2 entities)	10	$458
Artivion, Inc.	4	$342
Baxter Healthcare	5	$335
Abiomed	5	$249
Cook Medical LLC	2	$210
Getinge USA Sales, LLC	2	$125
Intuitive Surgical	2	$121
Zimmer Biomet	3	$58
Pfizer	3	$57
AstraZeneca	3	$56
Actelion Pharmaceuticals US, Inc.	2	$43
Livanova USA, Inc.	2	$41
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$40
Merck	2	$29
Medistim USA, Inc.	1	$27
Kiniksa Pharmaceuticals, Ltd.	1	$24
Johnson & Johnson	1	$22
Paladin Technology Solutions	1	$21
E.r. Squibb & Sons, L.L.C.	1	$20
Avanos Medical	1	$16
Clearflow Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

HeartMate 3 Left Ventricular Dev$3,317
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,811
Ensite Cardiac Mapping System$1,800
HeartMate 3 Left Ventricular Assist Device$1,453
SYNERGY ABLATION SYSTEM$1,448
Epic Stented Tissue Valve$991
ATRICLIP LAA EXCLUSION SYSTEM$638
CARDIOMEMS$287
Trifecta GT Tissue Heart Valve$265
Epic$252
2ND GEN CENTRIMAG PRIMARY CONSOLE$217
HeartMate$179
HeartWare HVAD$146
Impella$143
MitraClip$127
Cook Medical Stents$117
FLOSEAL$111
CentriMag$107
EDWARDS INTUITY Elite valve system$103
Avalus$100

How this compares

$20,302 in reported general payments places this provider in the 75th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$53,782

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Chlorhexidine Gluconate	20	$80

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in West Reading

Uday DasikaWest Reading$50K
Joseph BavariaAllentown$1.7M
Basel RamlawiWynnewood$1.1M
Patrick RossWynnewood$956K
Mark AndersonPhiladelphia$527K
Scott GoldmanWynnewood$354K
Frank BowenCamp Hill$310K
Michael AckerPhiladelphia$271K
Wilson SzetoPhiladelphia$252K
Inderpal SarkariaPittsburgh$248K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →